Latest releases

20.01.2022

PR

CEO transition; Herantis to focus on HER-096
13.01.2022

PR

Herantis Marks A Successful 2021; An Ambitious and Promising 2022 Ahead to Advance Robust CNS Pipeline
03.01.2022

PR

Herantis Pharma to Participate in the Upcoming Investor Conferences
15.12.2021

FN, GR

Herantis Pharma Plc’s Financial Calendar and Annual General Meeting for 2022
15.11.2021

PR

Composition of Herantis Pharma Plc’s Shareholders’ Nomination Committee
03.11.2021

FN, GR

Herantis Pharma to Participate in the Upcoming Investor Conferences
26.10.2021

FN, GR

Herantis Pharma Provides R&D Update and Information About New Biomarker Program
25.10.2021

FN, GR

Herantis Pharma Announces Members of Scientific Advisory Board
20.10.2021

FN, GR

Herantis Pharma to Host an R&D Update Webinar on October 26, 2021
30.09.2021

PR

Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease

Quick links

Company Presentation »

Stock Exchange & Press Releases »

Share and Shareholders »

Financial Reports »

Financial Calendar »

Analyst Coverage »

General Meetings »

Articles of Association »

Corporate Governance »

Investor Relations »

Subscription Service »